SBC Medical Group Holdings Incorporated SBC
4.90
0.15
3.16%
as of 25 Sep
- Market cap
- $488.5M
- P/E
- 10.4×
Follow SBC
Growth Flags
show if company had growth for consecutive years
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | |
|---|---|---|---|---|
P/E ratio |
8.80 | 11.44 | 26.38 | — |
P/S ratio |
2.56 | 2.61 | 0.00 | — |
P/FCF ratio |
14.91 | 31.26 | 20.08 | — |
P/Operating CF |
8.54 | (73.51) | 36.44 | — |
P/B ratio |
1.69 | 2.75 | 7.07 | — |
Price to Tangible BV |
2.22 | 2.84 | 8.44 | — |
EV/Sales |
1.86 | 2.04 | 0.00 | — |
EV/EBITDA |
4.60 | 5.65 | 12.67 | — |
EV/Operating CF |
13.08 | 20.33 | 18.30 | — |
EV/FCF |
10.84 | 24.36 | 18.30 | — |
Quick Ratio |
3.34 | 2.71 | 1.59 | 0.86 |
Current Ratio |
3.78 | 3.01 | 1.79 | 1.28 |
Net Debt/EBITDA |
(1.73) | (1.60) | (1.08) | 0.89 |
Debt/Assets |
11.29% | 2.48% | 5.09% | 0.00% |
Debt/Equity |
0.16 | 0.03 | 0.09 | 0.00 |
Asset Turnover |
0.54 | 0.78 | 1.02 | — |
Operating CF/Net income |
0.48 | 0.44 | 1.29 | (0.84) |
Capex/Depreciation |
1.90 | (0.90) | (0.26) | — |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 |
| 22.25% | 27.51% | 56.06% | 0.00% | |
| 15.77% | 17.76% | 20.79% | 0.00% | |
ROIC |
29.67% | 57.38% | 81.85% | 0.00% |
Return on Tangible Assets |
28.70% | 35.31% | 45.23% | 353.91% |
Average Days of Receivables |
83.64 | 72.22 | 82.22 | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | — |
Selling, General and Administrative Expense of Revenue |
34.44% | 34.41% | 34.22% | 0.00% |
Intangible Assets out of Total Assets |
0.17 | 0.02 | 0.09 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 6.34% | 0.00% | — |
Graham Net Nets |
0.26 | 0.21 | 0.05 | — |
Graham Number |
5.31 | 4.70 | 3.75 | — |
Earnings Yield |
11.37% | 8.74% | 3.79% | — |
Free Cash Flow Yield |
6.71% | 3.20% | 4.98% | — |
Revenue per Share |
1.69 | 2.13 | 2.05 | 0.00 |
Operating CF per Share |
0.24 | 0.21 | 0.54 | (0.17) |
Capex per Share |
0.05 | (0.04) | (0.03) | 0.00 |
Free Cash Flow per Share |
0.29 | 0.18 | 0.50 | (0.17) |
Cash per Share |
1.59 | 1.30 | 1.09 | 0.18 |
Shareholders Equity per Share |
2.56 | 2.02 | 1.53 | (1.25) |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.56 | 2.02 | 1.53 | (1.25) |
Free Cash Flow |
29.78 | 17.17 | 47.51 | (0.46) |
Working Capital |
170.10 | 123.26 | 73.45 | 0.16 |
Capital Expenditures |
5.11 | (3.41) | (3.16) | — |
Net Current Asset Value |
114.08 | 113.39 | 50.91 | (122.58) |
EV/EBIT |
4.78 | 5.95 | 13.13 | — |
Capex to Sales |
(0.03) | 0.02 | 0.02 | — |
Net Profit Margin |
29.37% | 22.69% | 20.34% | 0.00% |
Price to Operating Income |
6.58 | 7.64 | 14.40 | — |
| Other line items | ||||
Depreciation/Fixed assets |
0.36 | 0.43 | 0.90 | — |
Cash ROIC |
3.64% | 3.62% | 14.26% | 16.11% |
Accounts Receivable Turnover |
4.32 | 4.88 | 0.00 | — |
Accounts Payable Turnover |
2.88 | 2.40 | 4.23 | — |
Inventory Turnover |
21.61 | 21.53 | 0.00 | — |
Average Days of Payables |
138.99 | 107.46 | 172.20 | 0.00 |
Days of Inventory on Hand |
22.00 | 11.05 | 20.06 | — |
Average Receivables |
40.21 | 42.12 | — | — |
Average Payables |
16.09 | 20.53 | 13.31 | — |
Average Inventory |
2.14 | 2.29 | — | — |
Average Assets |
323.27 | 262.44 | 189.37 | — |
Average Common Equity |
229.16 | 169.42 | 70.23 | — |
Columns are period end dates